<DOC>
	<DOCNO>NCT00858156</DOCNO>
	<brief_summary>The primary objective study evaluate effect hepatic function pharmacokinetics single oral dose BG9928 subject mild moderate hepatic impairment subject normal hepatic function .</brief_summary>
	<brief_title>BG9928 Subjects With Hepatic Impairment</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Must age 18 75 , inclusive . Must Body Mass Index ( BMI ) 19 kg/m2 36 kg/m2 , inclusive . The following criterion apply subject enrol Groups 1 2 ( mild moderate hepatic impairment ) : Must stable hepatic disease ( i.e. , change disease status within last 2 month determine enrol Investigator ) laboratory clinical finding support diagnosis hepatic impairment . Must total ChildPugh score ( Section 22 , Appendix I ) 56 ( mild ) , 79 ( moderate ) . Must otherwise healthy determine Investigator basis prestudy physical examination , medical history , 12lead ECG , vital sign , clinical laboratory parameter . Subjects control hypertension problem directly associate primary diagnosis hepatic impairment may include . Subjects stable , mild , chronic concurrent disease , degenerative joint disease , may include . History allergic reaction methylxanthinecontaining compound . History seizure within past 10 year , use medication suppression seizure within past 5 year . History brain surgery , meningitis/encephalitis , penetrate head trauma , stroke , transient ischemic attack within past 6 month . History active ( within 6 month ) drug alcohol abuse , positive drug screen ( without medically indicate rationale ) , positive alcohol breath test Screening Day 2 . History Human Immunodeficiency Virus ( HIV ) antibody . Serious systemic infection ( e.g. , septicemia ) within 30 day prior Day 1 . Fever , body temperature &gt; 38oC , within 48 hour prior Day 1 . Active bacterial viral infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>